Total Payments
$83,017
2024 Payments
$1,004
Companies
37
Transactions
535
Medicare Patients
2,470
Medicare Billing
$303,783
Payment Breakdown by Category
Other$64,412 (77.6%)
Food & Beverage$9,484 (11.4%)
Consulting$6,069 (7.3%)
Travel$2,972 (3.6%)
Gifts$59.40 (0.1%)
Education$21.28 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $64,412 | 38 | 77.6% |
| Food and Beverage | $9,484 | 473 | 11.4% |
| Consulting Fee | $6,069 | 5 | 7.3% |
| Travel and Lodging | $2,972 | 15 | 3.6% |
| Gift | $59.40 | 1 | 0.1% |
| Education | $21.28 | 3 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $35,835 | 71 | $0 (2019) |
| Novo Nordisk Inc | $23,164 | 124 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $11,928 | 33 | $0 (2018) |
| Lilly USA, LLC | $4,370 | 36 | $0 (2024) |
| Corcept Therapeutics | $3,224 | 18 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $743.22 | 35 | $0 (2022) |
| SANOFI-AVENTIS U.S. LLC | $511.76 | 30 | $0 (2024) |
| Dexcom, Inc. | $410.95 | 20 | $0 (2024) |
| Amneal Pharmaceuticals LLC | $307.20 | 19 | $0 (2024) |
| ABBVIE INC. | $270.02 | 17 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,004 | 48 | Dexcom, Inc. ($158.24) |
| 2023 | $317.82 | 17 | Medtronic, Inc. ($93.42) |
| 2022 | $485.13 | 23 | Abbott Laboratories ($122.10) |
| 2021 | $189.93 | 5 | AstraZeneca Pharmaceuticals LP ($125.00) |
| 2020 | $5,279 | 6 | Novo Nordisk Inc ($5,279) |
| 2019 | $27,150 | 28 | Novo Nordisk Inc ($17,005) |
| 2018 | $15,315 | 158 | Janssen Pharmaceuticals, Inc ($8,087) |
| 2017 | $33,277 | 250 | Janssen Pharmaceuticals, Inc ($20,429) |
All Payment Transactions
535 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: DIABETES MEDICINE | ||||||
| 12/17/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/11/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $23.31 | General |
| Category: Durable Pump | ||||||
| 12/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: Diabetes | ||||||
| 12/04/2024 | Tandem Diabetes Care, Inc. | t:slim X2 Insulin Pump with Control-IQ (Device) | Food and Beverage | In-kind items and services | $51.77 | General |
| Category: Endocrinology | ||||||
| 12/03/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: Bone Health | ||||||
| 11/21/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $17.60 | General |
| 11/12/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $18.80 | General |
| Category: Insulin Pump | ||||||
| 10/31/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $1.83 | General |
| Category: Endocrinology | ||||||
| 10/30/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/24/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $23.26 | General |
| Category: Endocrinology | ||||||
| 10/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: Diabetes | ||||||
| 10/09/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $85.25 | General |
| Category: Endocrinology | ||||||
| 10/08/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $24.47 | General |
| Category: Durable Pump | ||||||
| 09/24/2024 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $19.07 | General |
| 09/19/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $24.59 | General |
| Category: Endocrinology | ||||||
| 09/17/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 09/10/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $23.31 | General |
| Category: Endocrinology | ||||||
| 08/29/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: Diabetes | ||||||
| 08/27/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: ENDOCRINOLOGY | ||||||
| 07/30/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $14.80 | General |
| 07/25/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $9.64 | General |
| Category: Diabetes | ||||||
| 07/23/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/28/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $8.62 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 610 | 1,011 | $236,172 | $81,858 |
| 2022 | 8 | 629 | 920 | $222,251 | $76,843 |
| 2021 | 10 | 609 | 826 | $179,657 | $74,908 |
| 2020 | 11 | 622 | 848 | $189,919 | $70,174 |
Total Patients
2,470
Total Services
3,605
Medicare Billing
$303,783
Procedure Codes
37
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 371 | 635 | $178,435 | $61,076 | 34.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 44 | 57 | $22,515 | $8,042 | 35.7% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 84 | 188 | $14,100 | $5,206 | 36.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 49 | 55 | $11,000 | $3,472 | 31.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 15 | 15 | $4,320 | $1,627 | 37.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 15 | 24 | $3,648 | $1,582 | 43.4% |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | Office | 2023 | 11 | 14 | $1,694 | $635.26 | 37.5% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 21 | 23 | $460.00 | $218.96 | 47.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 339 | 522 | $148,248 | $50,329 | 33.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 37 | 48 | $19,008 | $7,159 | 37.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 87 | 101 | $20,301 | $7,042 | 34.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 35 | 35 | $12,810 | $3,910 | 30.5% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 72 | 124 | $9,424 | $3,499 | 37.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 21 | 50 | $7,650 | $2,967 | 38.8% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 15 | 15 | $4,335 | $1,698 | 39.2% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 23 | 25 | $475.00 | $240.54 | 50.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 288 | 433 | $103,054 | $44,729 | 43.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 73 | 73 | $26,134 | $8,996 | 34.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 37 | 41 | $13,038 | $6,429 | 49.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 76 | 89 | $14,596 | $5,799 | 39.7% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Office | 2021 | 63 | 104 | $8,112 | $3,026 | 37.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 16 | 30 | $4,650 | $1,970 | 42.4% |
| 95250 | Ambulatory continuous glucose (sugar) monitoring for a minimum of 72 hours | Office | 2021 | 11 | 11 | $3,795 | $1,578 | 41.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 11 | 11 | $3,256 | $1,271 | 39.0% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 11 | 11 | $2,585 | $885.78 | 34.3% |
About Dr. Saima Farghani, MD
Dr. Saima Farghani, MD is a Endocrinology, Diabetes & Metabolism healthcare provider based in Manahawkin, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/12/2010. The National Provider Identifier (NPI) number assigned to this provider is 1982922183.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Saima Farghani, MD has received a total of $83,017 in payments from pharmaceutical and medical device companies, with $1,004 received in 2024. These payments were reported across 535 transactions from 37 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($64,412).
As a Medicare-enrolled provider, Farghani has provided services to 2,470 Medicare beneficiaries, totaling 3,605 services with total Medicare billing of $303,783. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism|Internal Medicine
- Location Manahawkin, NJ
- Active Since 05/12/2010
- Last Updated 04/23/2020
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1982922183
Products in Payments
- INVOKANA (Drug) $35,819
- JARDIANCE (Drug) $15,770
- Ozempic (Drug) $12,805
- Tresiba (Drug) $3,911
- Korlym (Drug) $3,224
- RYBELSUS (Drug) $2,525
- Xultophy 100/3.6 (Drug) $2,180
- FARXIGA (Drug) $743.22
- Victoza (Drug) $346.21
- UNITHROID (Drug) $336.46
- Dexcom G6 Transmitter (Medical Supply) $311.61
- TOUJEO (Drug) $223.93
- JANUVIA (Drug) $219.36
- HUMULIN (Drug) $212.14
- Saxenda (Drug) $196.29
- MINIMED 780G (Device) $161.99
- AFREZZA (Drug) $147.66
- Omnipod (Device) $133.98
- SOLIQUA (Drug) $131.08
- Minimed 670G System (Device) $127.53
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.